ID: ALA2114376

Max Phase: Preclinical

Molecular Formula: C10H13N

Molecular Weight: 147.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N[C@@H]1CCc2ccccc2C1

Standard InChI:  InChI=1S/C10H13N/c11-10-6-5-8-3-1-2-4-9(8)7-10/h1-4,10H,5-7,11H2/t10-/m1/s1

Standard InChI Key:  LCGFVWKNXLRFIF-SNVBAGLBSA-N

Associated Targets(non-human)

Phenylethanolamine N-methyltransferase 752 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 147.22Molecular Weight (Monoisotopic): 147.1048AlogP: 1.50#Rotatable Bonds: 0
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.03CX LogP: 1.93CX LogD: -0.56
Aromatic Rings: 1Heavy Atoms: 11QED Weighted: 0.59Np Likeness Score: 0.29

References

1. Grunewald GL, Ye QH..  (1988)  Stereochemical aspects of phenylethanolamine analogues as substrates of phenylethanolamine N-methyltransferase.,  31  (10): [PMID:3172133] [10.1021/jm00118a021]

Source